Source: Pharmacy Times articles
Small molecule agents continue to be beneficial additions to multiple myeloma treatment, even with the development of T-cell redirected therapies.
Read More
by | Sep 28, 2024 | Myeloma News | 0 comments
Source: Pharmacy Times articles
Small molecule agents continue to be beneficial additions to multiple myeloma treatment, even with the development of T-cell redirected therapies.
Read More